A - Human Necessities – 61 – F
Patent
A - Human Necessities
61
F
A61F 2/06 (2006.01) A61K 9/00 (2006.01) A61K 31/192 (2006.01) A61K 31/505 (2006.01) A61K 31/513 (2006.01) A61K 31/58 (2006.01) A61K 47/32 (2006.01) A61K 47/34 (2006.01) A61L 17/00 (2006.01) A61L 29/16 (2006.01) A61L 31/10 (2006.01) A61L 31/16 (2006.01) A61P 43/00 (2006.01) A61K 9/70 (2006.01)
Patent
CA 2460920
An intraluminal medical device comprises a stent having a coating applied to at least part of an interior surface, an exterior surface, or both. The coating comprises a sustained release formulation of a combination of pharmaceutical compounds dispersed within a biologically tolerated polymer composition. The choice of the combination of pharmaceutical compounds are intended to reduce neointimal hyperplasia restenosis.
Un dispositif médical intraluminal comprend une prothèse endovasculaire présentant un revêtement appliqué sur au moins une partie d'une surface intérieure, d'une surface extérieure ou des deux. Le revêtement contient une formulation à libération prolongée d'une combinaison de composés pharmaceutiques dispersés à l'intérieur d'une composition polymère biologiquement tolérée. Le choix de la combinaison de composés pharmaceutiques permet de réduire la resténose hyperplasique de la néointima.
Ashton Paul
Chen Jianbing
Borden Ladner Gervais Llp
Control Delivery Systems Inc.
Psivida Us Inc.
LandOfFree
Stent coated with a sustained-release drug delivery and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stent coated with a sustained-release drug delivery and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stent coated with a sustained-release drug delivery and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1996123